“…Both methods of presentation contain recommended cross-section data and the corresponding deduced yields. A second IAEA CRP was launched in 2003 to cover the production routes for established ( 103 Pd, 186 Re and 192 Ir) and emerging therapeutic radionuclides ( 64 Cu, 67 Cu,67 Ga, 86 Y, 111 In, 114m In, 124 I, 125 I, 169 Yb, 177 Lu,211 At and 225 Ac) totalling thirty-five reactions [7].…”